FDA inspection
Generics Bidco II LLC d/b/a Prinston Laboratories: FDA inspection ending Jun 15, 2022
FDA inspection 1173022 · No Action Indicated (NAI) · Charlotte, NC
Key facts
| Inspection ID | 1173022 |
|---|---|
| Firm | Generics Bidco II LLC d/b/a Prinston Laboratories |
| FEI number | 1038197 |
| Address | 3241 Woodpark Blvd |
| City | Charlotte |
| State | NC |
| ZIP | 28206-4212 |
| Fiscal year | 2022 |
| Inspection end date | Jun 15, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data